Joel Greenblatt Organogenesis Holdings Inc. Transaction History

Gotham Asset Management, LLC

  • $9.41 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
SELL
$4.74 - $8.15 $107,422 - $184,703
-22,663 Reduced 65.64%
11,865 $58,000
Q1 2022

May 16, 2022
SELL
$6.47 - $9.57 $8,986 - $13,292
-1,389 Reduced 3.87%
34,528 $263,000
Q4 2021

Feb 14, 2022
BUY
$9.02 - $13.5 $138,664 - $207,535
15,373 Added 74.83%
35,917 $332,000
Q3 2021

Nov 15, 2021
BUY
$13.71 - $17.18 $281,658 - $352,945
20,544 New
20,544 $293,000

Others Institutions Holding ORGO

# of Institutions
117
Shares Held
63.2M
Call Options Held
25K
Put Options Held
23.2K
View Full List

About Organogenesis Holdings Inc.

ORGO Quotes by TradingView
  • Ticker ORGO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 130,888,000
  • Market Cap $406M
  • Description
  • Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokin...
More about ORGO
Track Joel Greenblatt's Portfolio

Track Joel Greenblatt Portfolio

Follow Joel Greenblatt (Gotham Asset Management, LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gotham Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gotham Asset Management, LLC and Joel Greenblatt with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email